nodes	percent_of_prediction	percent_of_DWPC	metapath
Bezafibrate—PPARG—Irinotecan—Topotecan—cervical cancer	0.0428	1	CbGdCrCtD
Bezafibrate—PPARD—uterine cervix—cervical cancer	0.0282	0.0466	CbGeAlD
Bezafibrate—PPARD—decidua—cervical cancer	0.0269	0.0444	CbGeAlD
Bezafibrate—PPARD—mammalian vulva—cervical cancer	0.0247	0.0408	CbGeAlD
Bezafibrate—PPARA—epithelium—cervical cancer	0.0242	0.0401	CbGeAlD
Bezafibrate—PPARD—RXR and RAR heterodimerization with other nuclear receptor—RARB—cervical cancer	0.0225	0.0639	CbGpPWpGaD
Bezafibrate—PPARA—renal system—cervical cancer	0.0225	0.0372	CbGeAlD
Bezafibrate—PPARD—female reproductive system—cervical cancer	0.0211	0.0349	CbGeAlD
Bezafibrate—PPARD—female gonad—cervical cancer	0.0192	0.0318	CbGeAlD
Bezafibrate—PPARD—vagina—cervical cancer	0.0191	0.0316	CbGeAlD
Bezafibrate—PPARD—Nuclear Receptors in Lipid Metabolism and Toxicity—RARB—cervical cancer	0.0182	0.0515	CbGpPWpGaD
Bezafibrate—PPARA—female reproductive system—cervical cancer	0.018	0.0298	CbGeAlD
Bezafibrate—PPARA—RXR and RAR heterodimerization with other nuclear receptor—RARB—cervical cancer	0.0171	0.0486	CbGpPWpGaD
Bezafibrate—PPARD—Nuclear Receptors—RARB—cervical cancer	0.0166	0.0471	CbGpPWpGaD
Bezafibrate—PPARA—female gonad—cervical cancer	0.0164	0.0271	CbGeAlD
Bezafibrate—HMGCR—epithelium—cervical cancer	0.0161	0.0267	CbGeAlD
Bezafibrate—HMGCR—uterine cervix—cervical cancer	0.016	0.0265	CbGeAlD
Bezafibrate—HMGCR—decidua—cervical cancer	0.0152	0.0252	CbGeAlD
Bezafibrate—HMGCR—renal system—cervical cancer	0.015	0.0247	CbGeAlD
Bezafibrate—HMGCR—endometrium—cervical cancer	0.0145	0.0239	CbGeAlD
Bezafibrate—SLCO1B1—renal system—cervical cancer	0.0143	0.0237	CbGeAlD
Bezafibrate—HMGCR—mammalian vulva—cervical cancer	0.014	0.0231	CbGeAlD
Bezafibrate—PPARA—Nuclear Receptors in Lipid Metabolism and Toxicity—RARB—cervical cancer	0.0138	0.0393	CbGpPWpGaD
Bezafibrate—HMGCR—SREBP signalling—YY1—cervical cancer	0.0137	0.0389	CbGpPWpGaD
Bezafibrate—HMGCR—uterus—cervical cancer	0.0133	0.022	CbGeAlD
Bezafibrate—PPARG—epithelium—cervical cancer	0.0133	0.022	CbGeAlD
Bezafibrate—PPARD—Nuclear Receptor transcription pathway—RARB—cervical cancer	0.0131	0.0372	CbGpPWpGaD
Bezafibrate—PPARA—Nuclear Receptors—RARB—cervical cancer	0.0127	0.0359	CbGpPWpGaD
Bezafibrate—PPARG—decidua—cervical cancer	0.0126	0.0208	CbGeAlD
Bezafibrate—PPARG—renal system—cervical cancer	0.0124	0.0204	CbGeAlD
Bezafibrate—PPARD—lymph node—cervical cancer	0.0124	0.0204	CbGeAlD
Bezafibrate—PPARG—RXR and RAR heterodimerization with other nuclear receptor—RARB—cervical cancer	0.0123	0.0349	CbGpPWpGaD
Bezafibrate—HMGCR—female reproductive system—cervical cancer	0.012	0.0198	CbGeAlD
Bezafibrate—PPARG—mammalian vulva—cervical cancer	0.0116	0.0191	CbGeAlD
Bezafibrate—SLCO1B1—female reproductive system—cervical cancer	0.0115	0.019	CbGeAlD
Bezafibrate—PPARG—uterus—cervical cancer	0.011	0.0182	CbGeAlD
Bezafibrate—HMGCR—female gonad—cervical cancer	0.0109	0.018	CbGeAlD
Bezafibrate—HMGCR—vagina—cervical cancer	0.0108	0.0179	CbGeAlD
Bezafibrate—PPARA—lymph node—cervical cancer	0.0105	0.0174	CbGeAlD
Bezafibrate—PPARA—Nuclear Receptor transcription pathway—RARB—cervical cancer	0.01	0.0284	CbGpPWpGaD
Bezafibrate—PPARG—Nuclear Receptors in Lipid Metabolism and Toxicity—RARB—cervical cancer	0.00991	0.0281	CbGpPWpGaD
Bezafibrate—PPARG—female reproductive system—cervical cancer	0.0099	0.0164	CbGeAlD
Bezafibrate—PPARG—Noncanonical Wnt signaling pathway—WNT5A—cervical cancer	0.00982	0.0279	CbGpPWpGaD
Bezafibrate—PPARD—Wnt Signaling Pathway and Pluripotency—WNT2—cervical cancer	0.00939	0.0266	CbGpPWpGaD
Bezafibrate—PPARG—Nuclear Receptors—RARB—cervical cancer	0.00907	0.0257	CbGpPWpGaD
Bezafibrate—PPARG—female gonad—cervical cancer	0.00901	0.0149	CbGeAlD
Bezafibrate—PPARG—SREBP signalling—YY1—cervical cancer	0.00898	0.0255	CbGpPWpGaD
Bezafibrate—PPARG—vagina—cervical cancer	0.00896	0.0148	CbGeAlD
Bezafibrate—PPARG—Signaling events mediated by HDAC Class I—YY1—cervical cancer	0.00888	0.0252	CbGpPWpGaD
Bezafibrate—HMGCR—SREBF and miR33 in cholesterol and lipid homeostasis—MTOR—cervical cancer	0.00849	0.0241	CbGpPWpGaD
Bezafibrate—CYP2C8—renal system—cervical cancer	0.00815	0.0135	CbGeAlD
Bezafibrate—CYP1A1—epithelium—cervical cancer	0.00811	0.0134	CbGeAlD
Bezafibrate—CYP1A1—uterine cervix—cervical cancer	0.00804	0.0133	CbGeAlD
Bezafibrate—CYP2C8—endometrium—cervical cancer	0.00788	0.013	CbGeAlD
Bezafibrate—PPARA—SREBF and miR33 in cholesterol and lipid homeostasis—MTOR—cervical cancer	0.00777	0.022	CbGpPWpGaD
Bezafibrate—CYP1A1—renal system—cervical cancer	0.00753	0.0124	CbGeAlD
Bezafibrate—PPARG—Nuclear Receptor transcription pathway—RARB—cervical cancer	0.00717	0.0203	CbGpPWpGaD
Bezafibrate—PPARD—Wnt Signaling Pathway and Pluripotency—WNT5A—cervical cancer	0.00712	0.0202	CbGpPWpGaD
Bezafibrate—PPARA—Estrogen Receptor Pathway—STAT3—cervical cancer	0.00709	0.0201	CbGpPWpGaD
Bezafibrate—CYP1A1—mammalian vulva—cervical cancer	0.00704	0.0116	CbGeAlD
Bezafibrate—HMGCR—lymph node—cervical cancer	0.00701	0.0116	CbGeAlD
Bezafibrate—CYP1A1—uterus—cervical cancer	0.0067	0.0111	CbGeAlD
Bezafibrate—CYP2C8—female reproductive system—cervical cancer	0.00653	0.0108	CbGeAlD
Bezafibrate—CYP1A1—female reproductive system—cervical cancer	0.00603	0.00996	CbGeAlD
Bezafibrate—CYP2C8—vagina—cervical cancer	0.0059	0.00976	CbGeAlD
Bezafibrate—PPARD—Presenilin action in Notch and Wnt signaling—NOTCH1—cervical cancer	0.00585	0.0166	CbGpPWpGaD
Bezafibrate—PPARG—lymph node—cervical cancer	0.00579	0.00958	CbGeAlD
Bezafibrate—CYP3A4—renal system—cervical cancer	0.00552	0.00913	CbGeAlD
Bezafibrate—CYP1A1—female gonad—cervical cancer	0.00548	0.00907	CbGeAlD
Bezafibrate—CYP1A1—vagina—cervical cancer	0.00545	0.00901	CbGeAlD
Bezafibrate—PPARA—Developmental Biology—INSM1—cervical cancer	0.0048	0.0136	CbGpPWpGaD
Bezafibrate—CYP1A1—Tryptophan metabolism—UBE3A—cervical cancer	0.00471	0.0134	CbGpPWpGaD
Bezafibrate—HMGCR—TOR Signaling—MTOR—cervical cancer	0.00444	0.0126	CbGpPWpGaD
Bezafibrate—CYP3A4—female reproductive system—cervical cancer	0.00442	0.00731	CbGeAlD
Bezafibrate—PPARA—Circadian rythm related genes—UBE3A—cervical cancer	0.0041	0.0116	CbGpPWpGaD
Bezafibrate—PPARD—Presenilin action in Notch and Wnt signaling—CTNNB1—cervical cancer	0.00388	0.011	CbGpPWpGaD
Bezafibrate—CYP1A1—lymph node—cervical cancer	0.00353	0.00583	CbGeAlD
Bezafibrate—PPARG—Developmental Biology—INSM1—cervical cancer	0.00344	0.00977	CbGpPWpGaD
Bezafibrate—PPARG—Circadian rythm related genes—UBE3A—cervical cancer	0.00294	0.00833	CbGpPWpGaD
Bezafibrate—HMGCR—AMPK Signaling—MTOR—cervical cancer	0.00264	0.00749	CbGpPWpGaD
Bezafibrate—HMGCR—SREBP signalling—MTOR—cervical cancer	0.00264	0.00749	CbGpPWpGaD
Bezafibrate—CYP1A1—Estrogen Receptor Pathway—STAT3—cervical cancer	0.00251	0.00711	CbGpPWpGaD
Bezafibrate—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—RARB—cervical cancer	0.00241	0.00683	CbGpPWpGaD
Bezafibrate—CYP3A4—Tryptophan metabolism—UBE3A—cervical cancer	0.00232	0.00658	CbGpPWpGaD
Bezafibrate—PPARD—Generic Transcription Pathway—RARB—cervical cancer	0.00227	0.00643	CbGpPWpGaD
Bezafibrate—PPARG—Wnt Signaling Pathway Netpath—MTOR—cervical cancer	0.00217	0.00615	CbGpPWpGaD
Bezafibrate—CYP1A1—Aryl Hydrocarbon Receptor Pathway—HES1—cervical cancer	0.00209	0.00592	CbGpPWpGaD
Bezafibrate—PPARG—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CASP3—cervical cancer	0.00206	0.00584	CbGpPWpGaD
Bezafibrate—PPARD—Wnt Signaling Pathway and Pluripotency—CTNNB1—cervical cancer	0.00205	0.00583	CbGpPWpGaD
Bezafibrate—PPARG—Wnt Signaling Pathway Netpath—CTNNB1—cervical cancer	0.00192	0.00545	CbGpPWpGaD
Bezafibrate—PPARG—SREBP signalling—MTOR—cervical cancer	0.00173	0.00491	CbGpPWpGaD
Bezafibrate—PPARA—Generic Transcription Pathway—RARB—cervical cancer	0.00173	0.0049	CbGpPWpGaD
Bezafibrate—HMGCR—Integrated Breast Cancer Pathway—CASP8—cervical cancer	0.00171	0.00486	CbGpPWpGaD
Bezafibrate—PPARD—Adipogenesis—CTNNB1—cervical cancer	0.00169	0.0048	CbGpPWpGaD
Bezafibrate—PPARD—Ectoderm Differentiation—CTNNB1—cervical cancer	0.00161	0.00458	CbGpPWpGaD
Bezafibrate—HMGCR—AMPK Signaling—TP53—cervical cancer	0.00156	0.00441	CbGpPWpGaD
Bezafibrate—PPARD—Generic Transcription Pathway—NOTCH2—cervical cancer	0.0015	0.00426	CbGpPWpGaD
Bezafibrate—PPARD—Adipogenesis—STAT3—cervical cancer	0.00147	0.00418	CbGpPWpGaD
Bezafibrate—HMGCR—Integrated Breast Cancer Pathway—MTOR—cervical cancer	0.00141	0.004	CbGpPWpGaD
Bezafibrate—PPARD—Wnt Signaling Pathway and Pluripotency—TP53—cervical cancer	0.00137	0.00388	CbGpPWpGaD
Bezafibrate—PPARG—Signaling events mediated by HDAC Class I—STAT3—cervical cancer	0.00132	0.00375	CbGpPWpGaD
Bezafibrate—HMGCR—Integrated Breast Cancer Pathway—CASP3—cervical cancer	0.0013	0.00368	CbGpPWpGaD
Bezafibrate—PPARA—Adipogenesis—CTNNB1—cervical cancer	0.00129	0.00366	CbGpPWpGaD
Bezafibrate—HMGCR—Integrated Breast Cancer Pathway—CTNNB1—cervical cancer	0.00125	0.00355	CbGpPWpGaD
Bezafibrate—PPARG—Generic Transcription Pathway—RARB—cervical cancer	0.00124	0.00351	CbGpPWpGaD
Bezafibrate—PPARA—Generic Transcription Pathway—NOTCH2—cervical cancer	0.00114	0.00325	CbGpPWpGaD
Bezafibrate—PPARA—Adipogenesis—STAT3—cervical cancer	0.00112	0.00319	CbGpPWpGaD
Bezafibrate—PPARD—Gene Expression—RARB—cervical cancer	0.00109	0.0031	CbGpPWpGaD
Bezafibrate—PPARD—Metabolism—CA9—cervical cancer	0.000998	0.00283	CbGpPWpGaD
Bezafibrate—HMGCR—Integrated Breast Cancer Pathway—EGFR—cervical cancer	0.00099	0.00281	CbGpPWpGaD
Bezafibrate—PPARD—Generic Transcription Pathway—NOTCH1—cervical cancer	0.00093	0.00264	CbGpPWpGaD
Bezafibrate—PPARG—Adipogenesis—CTNNB1—cervical cancer	0.000924	0.00262	CbGpPWpGaD
Bezafibrate—PPARA—Developmental Biology—HES1—cervical cancer	0.000883	0.00251	CbGpPWpGaD
Bezafibrate—PPARA—Gene Expression—RARB—cervical cancer	0.000832	0.00236	CbGpPWpGaD
Bezafibrate—HMGCR—Metabolism—CA9—cervical cancer	0.000832	0.00236	CbGpPWpGaD
Bezafibrate—HMGCR—Integrated Breast Cancer Pathway—TP53—cervical cancer	0.000832	0.00236	CbGpPWpGaD
Bezafibrate—CYP1A1—Aryl Hydrocarbon Receptor Pathway—EGFR—cervical cancer	0.000829	0.00235	CbGpPWpGaD
Bezafibrate—CYP1A1—Aryl Hydrocarbon Receptor—EGFR—cervical cancer	0.000829	0.00235	CbGpPWpGaD
Bezafibrate—PPARG—Generic Transcription Pathway—NOTCH2—cervical cancer	0.00082	0.00233	CbGpPWpGaD
Bezafibrate—PPARG—Adipogenesis—STAT3—cervical cancer	0.000805	0.00228	CbGpPWpGaD
Bezafibrate—PPARA—Metabolism—CA9—cervical cancer	0.000761	0.00216	CbGpPWpGaD
Bezafibrate—PPARD—Gene Expression—NOTCH2—cervical cancer	0.000723	0.00205	CbGpPWpGaD
Bezafibrate—PPARA—Generic Transcription Pathway—NOTCH1—cervical cancer	0.000708	0.00201	CbGpPWpGaD
Bezafibrate—PPARA—Developmental Biology—NOTCH1—cervical cancer	0.000667	0.00189	CbGpPWpGaD
Bezafibrate—PPARG—Developmental Biology—HES1—cervical cancer	0.000633	0.0018	CbGpPWpGaD
Bezafibrate—PPARA—Circadian rythm related genes—TP53—cervical cancer	0.000605	0.00172	CbGpPWpGaD
Bezafibrate—PPARG—Gene Expression—RARB—cervical cancer	0.000596	0.00169	CbGpPWpGaD
Bezafibrate—PPARA—Gene Expression—NOTCH2—cervical cancer	0.000551	0.00156	CbGpPWpGaD
Bezafibrate—PPARG—Metabolism—CA9—cervical cancer	0.000545	0.00155	CbGpPWpGaD
Bezafibrate—PPARG—Generic Transcription Pathway—NOTCH1—cervical cancer	0.000508	0.00144	CbGpPWpGaD
Bezafibrate—PPARG—Developmental Biology—NOTCH1—cervical cancer	0.000478	0.00136	CbGpPWpGaD
Bezafibrate—PPARD—Gene Expression—NOTCH1—cervical cancer	0.000448	0.00127	CbGpPWpGaD
Bezafibrate—PPARA—Developmental Biology—CTNNB1—cervical cancer	0.000443	0.00126	CbGpPWpGaD
Bezafibrate—PPARG—Circadian rythm related genes—TP53—cervical cancer	0.000434	0.00123	CbGpPWpGaD
Bezafibrate—SLCO1B1—Metabolism—CA9—cervical cancer	0.000429	0.00122	CbGpPWpGaD
Bezafibrate—PPARD—Metabolism—MTHFR—cervical cancer	0.000405	0.00115	CbGpPWpGaD
Bezafibrate—PPARG—Gene Expression—NOTCH2—cervical cancer	0.000395	0.00112	CbGpPWpGaD
Bezafibrate—PPARA—Developmental Biology—STAT3—cervical cancer	0.000386	0.0011	CbGpPWpGaD
Bezafibrate—PPARA—Developmental Biology—EGFR—cervical cancer	0.000351	0.000996	CbGpPWpGaD
Bezafibrate—PPARA—Gene Expression—NOTCH1—cervical cancer	0.000341	0.000968	CbGpPWpGaD
Bezafibrate—HMGCR—Metabolism—MTHFR—cervical cancer	0.000337	0.000958	CbGpPWpGaD
Bezafibrate—PPARG—Developmental Biology—CTNNB1—cervical cancer	0.000317	0.000901	CbGpPWpGaD
Bezafibrate—PPARA—Metabolism—MTHFR—cervical cancer	0.000309	0.000876	CbGpPWpGaD
Bezafibrate—PPARG—Developmental Biology—STAT3—cervical cancer	0.000277	0.000785	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism—CA9—cervical cancer	0.000269	0.000763	CbGpPWpGaD
Bezafibrate—PPARG—Developmental Biology—EGFR—cervical cancer	0.000251	0.000714	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism—CA9—cervical cancer	0.000247	0.0007	CbGpPWpGaD
Bezafibrate—PPARG—Gene Expression—NOTCH1—cervical cancer	0.000244	0.000693	CbGpPWpGaD
Bezafibrate—PPARG—Metabolism—MTHFR—cervical cancer	0.000221	0.000628	CbGpPWpGaD
Bezafibrate—SLCO1B1—Metabolism—MTHFR—cervical cancer	0.000174	0.000494	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—CA9—cervical cancer	0.000132	0.000376	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism—MTHFR—cervical cancer	0.000109	0.00031	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism—MTHFR—cervical cancer	0.0001	0.000284	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—MTHFR—cervical cancer	5.37e-05	0.000152	CbGpPWpGaD
